BUDDATE REGES INTENSIVE TREATMENT (BUDDATE Co Ltd)
Welcome to the PulseAid listing for the BUDDATE REGES INTENSIVE TREATMENT drug offered from BUDDATE Co Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BUDDATE Co Ltd |
| NON-PROPRIETARY NAME: | Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7 |
| SUBSTANCE NAME: | PALMITOYL TETRAPEPTIDE-7; SHEA BUTTER; PALMITOYL TRIPEPTIDE-1; BUTYLENE GLYCOL; HYDROGENATED COCONUT OIL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2017-01-01 |
| END MARKETING DATE: | 0000-00-00 |
BUDDATE REGES INTENSIVE TREATMENT HUMAN OTC DRUG Details:
| Item Description | BUDDATE REGES INTENSIVE TREATMENT from BUDDATE Co Ltd |
| LABELER NAME: | BUDDATE Co Ltd |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .000006; 3; .000006; 5.57; 4(g/100mL; g/100mL; g/100mL; g/100mL; g/100mL) |
| START MARKETING DATE: | 2017-01-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 71173-3000_46495321-fb15-3479-e054-00144ff88e88 |
| PRODUCT NDC: | 71173-3000 |
| APPLICATION NUMBER: | |
Other PALMITOYL TETRAPEPTIDE-7; SHEA BUTTER; PALMITOYL TRIPEPTIDE-1; BUTYLENE GLYCOL; HYDROGENATED COCONUT OIL Pharmaceutical Manufacturers / Labelers:
